Kestra Advisory Services, LLC Ampio Pharmaceuticals, Inc. Transaction History

Kestra Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	BUY	$0.56 - $1.71 $72,171 - $220,381	128,878 New	128,878 $73,000
Q1 2021 May 10, 2021	SELL	$1.36 - $2.49 $64,396 - $117,901	-47,350 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$0.75 - $2.76 $27,562 - $101,429	36,750 Added 346.7%	47,350 $70 Million
Q3 2020 Nov 12, 2020	BUY	$0.61 - $1.17 $6,466 - $12,402	10,600 New	10,600 $10 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.